[HTML][HTML] Anti-PfGARP kills parasites by inducing PCD and attenuates severe malaria

DK Raj, AD Mohapatra, A Jnawali, J Zuromski, A Jha… - Nature, 2020 - ncbi.nlm.nih.gov
Malaria caused by Plasmodium falciparum remains the leading single-agent killer of
children 1, yet the promise of an effective vaccine remains unfulfilled. Using our differential …

Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria

DK Raj, A Das Mohapatra, A Jnawali, J Zuromski… - Nature, 2020 - nature.com
Malaria caused by Plasmodium falciparum remains the leading single-agent cause of
mortality in children, yet the promise of an effective vaccine has not been fulfilled. Here …

Antibodies to Plasmodium falciparum glutamic acid rich protein (PfGARP) inhibit parasite growth by arresting trophozoite development

DK Raj, C Nixon, S Pond-Torl, J Kurtis - International Journal of …, 2016 - ijidonline.com
Background: Malaria affects almost one-half of the world's population and causes more than
600,000 deaths annually. Young children in malaria endemic areas of Africa have the …

A novel vaccine target for malaria

KH Wrighton - Nat Rev Drug Discov, 2020 - nature.com
Developing a vaccine to prevent malaria caused by the parasite Plasmodium falciparum has
proved highly challenging. Raj et al. now show that P. falciparum glutamic acid-rich protein …

Assessing PfGARP-Mediated Apoptosis of Blood-Stage Plasmodium falciparum Parasites

AD Mohapatra, J Zuromski, J Kurtis - Malaria Immunology: Targeting the …, 2022 - Springer
Apoptosis is conventionally regarded as an evolutionarily conserved and genetically
controlled process of programmed cell death confined to metazoan organisms. However …

Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia… - Nature medicine, 2019 - nature.com
Results: Published text:“Four of the five monoclonal antibodies (CIS23, CIS34, CIS42 and
CIS43) showed dose-dependent binding to rPfCSP and PfSPZ in an ELISA and had …

Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection

DK Raj, CP Nixon, CE Nixon, JD Dvorin, CG DiPetrillo… - Science, 2014 - science.org
Novel vaccines are urgently needed to reduce the burden of severe malaria. Using a
differential whole-proteome screening method, we identified Plasmodium falciparum …

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria

PC Bull, BS Lowe, M Kortok, CS Molyneux… - Nature medicine, 1998 - nature.com
The feasibility of a malaria vaccine is supported by the fact that children in endemic areas
develop naturally acquired immunity to disease. Development of disease immunity is …

Plasmodium falciparum Glutamic Acid-Rich Protein-Independent Polyclonal Antibodies Inhibit Malaria Parasite Growth in Human Erythrocytes

CJ Schwake, RM Krueger, T Hanada… - The Journal of …, 2024 - academic.oup.com
Plasmodium falciparum glutamic acid-rich protein (PfGARP) is a recently characterized cell
surface antigen encoded by Plasmodium falciparum, the causative agent of severe human …

Malaria according to GARP: a new trail towards anti-disease vaccination

C Hon, K Matuschewski - Trends in parasitology, 2020 - cell.com
Naturally acquired anti-Plasmodium falciparum immunity protects first and foremost against
severe disease. Raj et al. have established a tantalizing path towards an anti-disease …